The Relationship between Polycystic Ovarian Syndrome and Helicobacter Pylori in the Mid-Euphrates Region of Iraq
DOI:
https://doi.org/10.46966/msjar.v7i3.432Keywords:
Keywords: hyperandrogenism, C-reactive protein, interleukin-6, polycystic ovary syndrome and Helicobacter pylori infectionAbstract
Background: Polycystic Ovarian Syndrome (PCOS) is one of the common endocrinopathies. Infertility may result from persistent infections. Two common causes of infertility are Helicobacter pylori infection and PCOS. As far as we know, no research has connected H. pylori seropositivity to PCOS. The aim: investigate the impact of Helicobacter pylori (H. pylori) infections on metabolic and hormonal factors, as well as long-term inflammation indicators, in patients with polycystic ovary syndrome (PCOS). Materials and techniques: We examined 40 healthy women of the same age and 60 women with PCOS. We examined sex steroid-binding globulin (SSBG), total testosterone (TTest), oestradiol, C-reactive protein (CRP), interleukin-6 (IL-6) and IgG antibodies to H. pylori. These parameters were evaluated depending on whether an H. pylori infection was present or not. Results: Depending on whether an H. pylori infection was present or not, the following outcomes were observed: In the control group, 17.5% of participants were found to have raised IgG antibodies to H. pylori, while their CRP and homocysteine levels increased and their CRP concentration decreased. H. pylori infection was much more prevalent in PCOS patients (χ² = 7.7; P < 0.01). Conclusions: It has been demonstrated that PCOS patients have a higher prevalence of elevated blood CRP and IL-6 levels. The findings demonstrate a strong correlation between H. pylori infection and PCOS, which exacerbates the metabolic and hormonal issues already present and raises CRP and IL-6 levels.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Shaymaa Raouf Tawfeeq

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















